peptide,mhc_binding,expression_tpm,evasion_features,evasion_susceptibility,evasion_mechanisms,evasion_resistance_score
YLQPRTFLL,"{'HLA-A*02:01': {'binding_score': 0.8, 'strong_binder': True}}",8.5,"{'conservation_score': 0.6919610767971118, 'mutation_frequency': 0.10222222222222223, 'mhc_binding_strength': 0.8, 'expression_level': 0.85, 'tissue_specificity': 0.4100142881564312, 'immunodominance': 0.68, 'structural_accessibility': 0.15384079148041205}",0.014503770344824014,"{'mhc_downregulation': {'susceptibility': 0.8, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}, 'immunosuppression': {'susceptibility': 0.31999999999999995, 'resistance_strategies': ['checkpoint_inhibitors', 'adjuvants']}, 'regulatory_t_cells': {'susceptibility': 0.4100142881564312, 'resistance_strategies': ['treg_depletion', 'th1_polarization']}}",0.6524168466316193
KIADYNYKL,"{'HLA-A*02:01': {'binding_score': 0.7, 'weak_binder': True}}",12.3,"{'conservation_score': 0.5748473460344705, 'mutation_frequency': 0.10222222222222223, 'mhc_binding_strength': 0.7, 'expression_level': 1, 'tissue_specificity': 0.40145753380140553, 'immunodominance': 0.861, 'structural_accessibility': 0.9202020792068158}",0.0412151039194287,"{'mhc_downregulation': {'susceptibility': 0.7, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}, 'immunosuppression': {'susceptibility': 0.139, 'resistance_strategies': ['checkpoint_inhibitors', 'adjuvants']}, 'regulatory_t_cells': {'susceptibility': 0.40145753380140553, 'resistance_strategies': ['treg_depletion', 'th1_polarization']}}",0.6289188561754672
SLYNTVATL,"{'HLA-A*02:01': {'binding_score': 0.9, 'strong_binder': True}}",15.2,"{'conservation_score': 0.6618460439848561, 'mutation_frequency': 0.10222222222222223, 'mhc_binding_strength': 0.9, 'expression_level': 1, 'tissue_specificity': 0.38279345697819384, 'immunodominance': 1, 'structural_accessibility': 0.808542641000655}",0.06331690717897821,"{'mhc_downregulation': {'susceptibility': 0.9, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}, 'immunosuppression': {'susceptibility': 0, 'resistance_strategies': ['checkpoint_inhibitors', 'adjuvants']}, 'regulatory_t_cells': {'susceptibility': 0.38279345697819384, 'resistance_strategies': ['treg_depletion', 'th1_polarization']}}",0.6838525217399668
GILGFVFTL,"{'HLA-A*02:01': {'binding_score': 0.6, 'weak_binder': True}}",6.8,"{'conservation_score': 0.48328481252281574, 'mutation_frequency': 0.11333333333333334, 'mhc_binding_strength': 0.6, 'expression_level': 0.6799999999999999, 'tissue_specificity': 0.3742576207334122, 'immunodominance': 0.408, 'structural_accessibility': 0.9087966431803357}",0.01271575010355076,"{'mhc_downregulation': {'susceptibility': 0.6, 'resistance_strategies': ['mhc_ii_targeting', 'nk_cell_activation']}, 'immunosuppression': {'susceptibility': 0.5920000000000001, 'resistance_strategies': ['checkpoint_inhibitors', 'adjuvants']}, 'regulatory_t_cells': {'susceptibility': 0.3742576207334122, 'resistance_strategies': ['treg_depletion', 'th1_polarization']}}",0.673531774741545
